|
Volumn 22, Issue 2, 2001, Pages 209-210
|
Low-dose oral methotrexate treatment in chronic progressive multiple sclerosis
a a a a a a a a a |
Author keywords
Interferon; Methotrexate; Multiple sclerosis; Review
|
Indexed keywords
METHOTREXATE;
ANTIINFLAMMATORY ACTIVITY;
CLINICAL ARTICLE;
CONFERENCE PAPER;
DISEASE COURSE;
DOSE RESPONSE;
DRUG SAFETY;
ENZYME ASSAY;
FOLLOW UP;
HERPES ZOSTER;
HUMAN;
IMMUNOMODULATION;
LIVER TOXICITY;
LONG TERM CARE;
MULTIPLE SCLEROSIS;
NUCLEAR MAGNETIC RESONANCE IMAGING;
PRESCHOOL CHILD;
SCHOOL CHILD;
SIDE EFFECT;
ADULT;
DOSE-RESPONSE RELATIONSHIP, DRUG;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
MAGNETIC RESONANCE IMAGING;
METHOTREXATE;
MIDDLE AGED;
MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE;
TREATMENT OUTCOME;
|
EID: 0034791382
PISSN: 15901874
EISSN: None
Source Type: Journal
DOI: 10.1007/s100720170026 Document Type: Conference Paper |
Times cited : (25)
|
References (5)
|